Last updated: April 23, 2026
Who Supplies Phentermine Hydrochloride in the Pharmaceutical Supply Chain?
Phentermine hydrochloride is a controlled appetite-suppressant API used in obesity/weight-loss drug products. The supplier landscape is typically split between (1) API manufacturers and (2) contract manufacturing organizations (CMOs) that formulate and package finished dosage forms. Downstream availability depends on regulatory licensing, controlled-substance handling, and compliance with DEA and country-specific controls.
What types of companies supply phentermine hydrochloride?
Supply comes from three main channels:
-
API manufacturers (phentermine HCl)
- Produce phentermine hydrochloride as the active pharmaceutical ingredient.
- Provide documentation for quality, including GMP manufacturing and regulatory filings that support finished-dose product manufacturing.
-
CMOs for finished dosage forms (tablets/capsules)
- Purchase API and manufacture finished products under the sponsor’s NDA/ANDA or commercial supply agreements.
- Handle controlled-substance logistics, packaging, labeling, and batch release testing.
-
Distributors and logistics partners
- Move controlled APIs and finished dosage forms through licensed channels.
- Often do not make the API; they support supply continuity and inventory management.
Which suppliers manufacture phentermine hydrochloride API?
A complete, auditable list of current phentermine hydrochloride API suppliers requires access to up-to-date regulatory product listings (for example, DEA registrations and current Drug Master Files) and current commercial catalogs. This is not provided in the available information set.
No complete or reliable supplier roster can be produced without risking misidentification of manufacturers, outdated registrations, or incorrect attribution to specific API sources.
Which CMOs supply phentermine hydrochloride finished products?
Same constraint: a current and comprehensive roster of CMOs that actively support phentermine HCl dosage form manufacturing requires live market data tied to controlled-substance manufacturing authorizations and active contracts. That data is not present in the provided information set.
No complete or accurate list can be produced.
What does “supplier” mean for diligence on phentermine hydrochloride?
For business and R&D due diligence, “supplier” should be treated as three separate qualification tracks:
- API manufacturing qualification
- GMP status for API manufacture
- Controlled-substance procurement and handling capability
- Batch documentation readiness (CoA, impurity profile, stability program inputs)
- Finished-dose manufacturing qualification
- Licensed controlled-substance manufacturing and warehousing
- Validation history for compression/coating processes used for phentermine tablets or capsules
- Release testing scope
- Supply continuity and compliance
- DEA registration alignment (US) and equivalent controls in the target geography
- Licensed distribution chain integrity
Regulatory controls that gate supplier eligibility (high impact)
Phentermine is regulated as a controlled substance in the US. Supplier eligibility is gated by controlled-substance registrations and manufacturing authorization.
How does DEA control affect sourcing?
In the US, entities that manufacture, distribute, or handle controlled substances must be registered under the Controlled Substances Act and follow DEA rules for recordkeeping, security, and distribution. This directly limits the number of eligible suppliers and can affect lead times and allocation during constrained periods.
Source: DEA Controlled Substances Act overview and registration framework [1].
Key vendor screening criteria for phentermine hydrochloride
Use the same diligence rubric for any API or CMO supplier:
- Regulatory licensing
- Controlled-substance registrations for manufacture and distribution in the relevant jurisdiction(s)
- GMP and documentation
- Current GMP certifications and audit history
- Ability to provide CoAs, impurity/starting-material documentation, and batch reproducibility evidence
- Quality systems
- Change control and deviation management maturity
- Supply chain resilience
- Back-up sources for key intermediates and controlled starting materials
- Commercial terms
- Long-term supply commitments, allocation policy, and lead-time structure
Key Takeaways
- Phentermine hydrochloride sourcing is constrained by controlled-substance regulation and licensing requirements, so eligibility depends on DEA (or equivalent) authorization and controlled-substance handling capability.
- The supplier landscape splits into API manufacturers, CMOs for finished dosage forms, and licensed distributors.
- A complete, current supplier list cannot be produced from the information provided without risking inaccuracies.
FAQs
1) Are phentermine hydrochloride suppliers limited in number?
Yes. Controlled-substance manufacturing and distribution rules restrict the number of qualified API and finished-dose supply providers.
2) What matters most when qualifying a phentermine hydrochloride supplier?
Controlled-substance licensing and GMP capability, then documentation readiness (CoA, impurity profile, batch traceability).
3) Can a distributor source phentermine hydrochloride from any manufacturer?
No. Distributors must operate within licensed controlled-substance distribution channels, and the manufacturing source must be eligible.
4) Do API and finished-dose manufacturing suppliers have the same qualifications?
No. API manufacturers need controlled-substance API production and GMP for API; CMOs need controlled-substance finished-dose manufacturing and validated drug product processes.
5) How do supply constraints typically show up for phentermine HCl?
Through allocation, longer lead times, or reduced availability of API or dosage form inventory when licensed supply capacity is constrained.
References
[1] U.S. Drug Enforcement Administration. (n.d.). Controlled Substances Act and DEA registration requirements (overview and compliance framework). DEA. https://www.dea.gov/
